Filtros de búsqueda

Lista de obras de Vibeke Strand

A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis ⬇️

artículo científico publicado el 1 de febrero de 2011

A first step to assess harm and benefit in clinical trials in one scale

artículo científico publicado en 2009

A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis

artículo científico publicado en 2021

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative ⬇️

artículo científico publicado en 2017

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

artículo científico publicado en 2003

Adiposity in Juvenile Psoriatic Arthritis.

artículo científico publicado en 2017

Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis

artículo científico publicado en 2019

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials ⬇️

artículo científico publicado en 2011

Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies

artículo científico publicado en 2016

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmona

artículo científico

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis

scientific article published on 1 February 2020

Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews

artículo científico publicado en 2020

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations ⬇️

artículo científico publicado en 2016

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib

artículo científico publicado en 2020

Biologic therapies in rheumatology: lessons learned, future directions

artículo científico publicado en 2007

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

artículo científico publicado en 2015

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group st

artículo científico publicado en 2008

Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial

artículo científico publicado en 2011

Classification and Outcome Measures for Psoriatic Arthritis

article

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review

artículo científico publicado en 2020

Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials

artículo científico publicado en 2014

Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial

artículo científico publicado en 2004

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

scientific article published on 30 October 2018

Comparison of the Genant-modified Sharp and van der Heijde-modified Sharp scoring methods for radiographic assessment in rheumatoid arthritis

scholarly article by Charles G Peterfy et al published February 2011 in International journal of clinical rheumatology

Computer based methods for measurement of joint space width: update of an ongoing OMERACT project

artículo científico publicado en 2007

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2002

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group

artículo científico publicado en 2015

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

artículo científico publicado en 2014

Consensus on a core set of domains for psoriatic arthritis

artículo científico publicado en 2007

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

scientific article published on 1 June 2018

Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran

artículo científico publicado en 2010

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology

artículo científico publicado en 2019

Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis

scientific article published on 01 March 2019

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

scientific article published on 01 April 2020

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

artículo científico publicado en 2020

Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

artículo científico publicado en 2002

Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report.

artículo científico publicado en 2017

Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda

artículo científico publicado en 2015

Damage and progression on radiographs in individual joints: data from pivotal randomized controlled trials

artículo científico publicado en 2011

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

artículo científico publicado en 2017

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.

artículo científico publicado en 2007

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group

artículo científico publicado en 2016

Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.

artículo científico

Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease

artículo científico publicado en 2011

Development and Validation of a Novel Evidence-Based Lupus Multivariable Outcome Score for Clinical Trials.

artículo científico publicado en 2018

Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus

artículo científico publicado en 2014

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.

artículo científico

Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group

artículo científico publicado en 2011

Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry

artículo científico publicado en 2017

Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity

artículo científico publicado en 2016

Early postoperative mortality following joint arthroplasty: a systematic review

artículo científico publicado en 2011

Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group

scientific article published on December 2009

Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US.

scientific article published on 15 September 2016

Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial

artículo científico publicado en 2002

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

artículo científico publicado en 2009

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond

Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale

artículo científico publicado en 2019

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial

artículo científico publicado en 2002

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus

artículo científico publicado en 2004

Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials

artículo científico publicado en 2016

Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs

artículo científico publicado en 2015

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Randomized, Double-blind, Active-comparator, Multi-center, Multi-country Trial

artículo científico publicado en 2020

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

artículo científico publicado en 2016

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

artículo científico publicado en 2014

Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up

artículo científico publicado en 2013

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial

artículo científico publicado en 2018

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

scientific article published on 15 February 2019

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets ⬇️

artículo científico publicado en 2017

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014

artículo científico

Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.

artículo científico publicado en 2013

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop

artículo científico publicado en 2019

Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease

artículo científico publicado en 2017

Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation Requirements.

artículo científico

Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis

scientific article published on 24 April 2009

Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.

artículo científico publicado en 2018

Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.

artículo científico

Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis

artículo científico publicado en 2005

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study.

artículo científico publicado en 2019

From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials

artículo científico publicado en 2013

Functional impairment measurement in psoriatic arthritis: Importance and challenges

artículo científico publicado en 2018

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

artículo científico publicado en 2017

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

artículo científico publicado en 2017

Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT.

artículo científico publicado en 2015

Health-Related Quality of Life in Rheumatoid Arthritis

article

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

article

Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study

Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study

artículo científico publicado en 2011

High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis ⬇️

artículo científico publicado el 2 de febrero de 2011

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

artículo científico publicado en 2020

How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

artículo científico

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion

artículo científico publicado en 2002

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials

artículo científico publicado en 2019

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative

artículo científico publicado en 2019

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.

artículo científico publicado en 2012

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.

artículo científico publicado en 2011

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

artículo científico publicado en 2017

Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

scientific article published on 01 February 2020

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks

artículo científico publicado en 2020

Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry

artículo científico publicado en 2015

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.

artículo científico publicado en 2018

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

artículo científico publicado en 2017

Importance of 'meeting of the minds': patient-reported outcomes and MRI.

artículo científico publicado en 2016

Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials

artículo científico publicado en 2012

Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.

artículo científico publicado en 2007

Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.

scientific article published on April 2008

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept

artículo científico publicado en 2017

Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study

artículo científico publicado en 2012

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

artículo científico publicado en 2013

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

scientific article published on 15 January 2019

Infections in the Era of Targeted Therapies: Mapping the Road Ahead

scientific article published on 18 August 2020

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology

artículo científico publicado en 2019

Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis

artículo científico publicado en 2010

Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update

artículo científico publicado en 2021

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

artículo científico publicado en 2016

Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

artículo científico publicado en 2020

Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic Pain

artículo científico publicado en 2015

It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.

artículo científico publicado en 2011

Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial

artículo científico publicado en 2020

Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 pivotal studies

artículo científico publicado en 2020

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)

artículo científico publicado en 2018

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis

scientific article published on 26 October 2019

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study

artículo científico publicado en 2003

Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysis.

artículo científico publicado en 2003

Leflunomide or methotrexate for juvenile rheumatoid arthritis

artículo científico publicado en 2005

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.

artículo científico publicado en 2018

Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study

artículo científico publicado en 2015

Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

artículo científico publicado en 2013

Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial

artículo científico publicado en 2017

Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study

artículo científico

MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.

artículo científico publicado en 2003

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda

artículo científico publicado en 2003

Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.

artículo científico publicado en 2011

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review

artículo científico publicado en 2020

Measurement properties of the minimal disease activity criteria for psoriatic arthritis

artículo científico publicado en 2019

Measuring Worker Productivity: Frameworks and Measures

article

Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain

artículo científico publicado en 2014

Minimizing efficacy differences between phase II and III RCTs

artículo científico publicado en 2020

Ms. A.M. Taylor, et al reply ⬇️

artículo científico publicado en 2016

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

artículo científico publicado en 2018

Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity

artículo científico publicado en 2010

Novel evidence-based systemic lupus erythematosus responder index

artículo científico publicado en 2009

OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritis

artículo científico

OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials.

artículo científico publicado en 2011

OMERACT 11: international consensus conference on outcome measures in rheumatology.

artículo científico publicado en 2014

OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trials.

artículo científico publicado en 2009

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies

scientific article published on 15 February 2019

OMERACT endorsement of measures of outcome for studies of acute gout

artículo científico publicado en 2013

OMERACT workshop: repair of structural damage in rheumatoid arthritis

artículo científico publicado el 1 de mayo de 2003

OMERACT: An Ongoing Evidence-Based Initiative to Improve the Quality of Outcome Measures in Rheumatology

article

OMERACT: an international initiative to improve outcome measurement in rheumatology

artículo científico publicado en 2007

Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop

artículo científico publicado en 2015

Outcome measures in psoriatic arthritis

artículo científico publicado en 2007

Outcome measures in psoriatic arthritis

artículo científico publicado en 2005

Outcome measures in rheumatoid arthritis: the OMERACT process

scholarly article by Peter Brooks et al published May 2007 in Expert Review of Clinical Immunology

Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria

artículo científico publicado en 2003

Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients with Rheumatoid Arthritis Worldwide: An OMERACT Systematic Review

scientific article published on 31 January 2020

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.

artículo científico publicado en 2015

Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings

scientific article published on 20 August 2020

Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system

artículo científico publicado en 2016

Patient Burden of Axial Spondyloarthritis

artículo científico publicado en 2017

Patient Expectations and Perceptions of Goal-setting Strategies for Disease Management in Rheumatoid Arthritis.

artículo científico publicado en 2015

Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).

artículo científico publicado en 2015

Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

scientific article published on 01 October 2019

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

artículo científico publicado en 2018

Patient-reported outcomes in chronic gout: a report from OMERACT 10

scientific article published in July 2011

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

scientific article published on 30 August 2020

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis

artículo científico publicado en 2005

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol

artículo científico publicado en 2010

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

scientific article published on 30 April 2020

Predictors of self-reported health-related quality of life in systemic lupus erythematosus

artículo científico publicado en 2013

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.

artículo científico publicado en 2016

Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis.

artículo científico publicado en 2013

Proceedings of the 2012 Rheumatology Winter Clinical Symposia

artículo científico publicado en 2012

Proceedings of the 2013 Rheumatology Winter Clinical Symposia

artículo científico

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016.

artículo científico publicado en 2017

Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.

artículo científico

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

article

Putting the value into biosimilar decision making: the judgment value criteria

artículo científico

Qualifying unmet needs and improving standards of care in psoriatic arthritis

artículo científico publicado en 2014

Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?

artículo científico publicado en 2003

Randomized controlled trial design in rheumatoid arthritis: the past decade

artículo científico publicado en 2009

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized cont

artículo científico publicado en 2009

Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleis

scientific article published on 03 March 2017

Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases

artículo científico publicado en 2014

Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease

artículo científico publicado en 2013

Relation between fatigue and ACR response in patients with psoriatic arthritis treated with TNFi therapy: a population-based cohort study

artículo científico publicado en 2020

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

artículo científico publicado en 2005

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis

artículo científico publicado en 2016

Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions

artículo científico publicado el 1 de mayo de 2003

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting

artículo científico publicado en 2016

Review of the Psoriatic Arthritis Working Group at OMERACT 12: A Report from the GRAPPA 2014 Annual Meeting

artículo científico publicado en 2015

Rheumatoid arthritis

artículo científico publicado en 2018

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

artículo científico publicado en 2006

Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis

artículo científico publicado en 2010

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

artículo científico publicado en 2020

Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors

artículo científico publicado en 2017

Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial.

artículo científico publicado en 2016

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials

scientific article published on 23 November 2020

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1).

artículo científico publicado en 2016

Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE

artículo científico publicado en 2018

Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds

artículo científico publicado en 2014

Serum urate in chronic gout - will it be the first validated soluble biomarker in rheumatology?

artículo científico publicado en 2011

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials ⬇️

artículo científico publicado en 2016

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.

artículo científico publicado en 2017

Spondyloarthritis is associated with poor function and physical health-related quality of life

artículo científico publicado en 2009

Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups

artículo científico publicado en 2018

Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT). ⬇️

artículo científico publicado en 2016

Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial

artículo científico publicado en 2012

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

artículo científico publicado en 2016

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

artículo científico publicado en 2015

Systemic sclerosis - continuing progress in developing clinical measures of response.

artículo científico publicado en 2007

The 2018 OMERACT Synovial Tissue Biopsy Special Interest Group Report on Standardization of Synovial Biopsy Analysis

artículo científico publicado en 2019

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

artículo científico publicado en 2019

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

artículo científico publicado en 2020

The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes

artículo científico publicado en 2017

The changing landscape of biosimilars in rheumatology

artículo científico publicado en 2016

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

artículo científico publicado en 2012

The impact of rheumatoid arthritis and treatment on patients' lives.

artículo científico publicado en 2010

The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

artículo científico publicado en 2002

The role of biosimilars in the treatment of rheumatic diseases

artículo científico publicado en 2012

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis

artículo científico publicado en 2016

The unmet need in rheumatology: Reports from the targeted therapies meeting 2017.

artículo científico publicado en 2017

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

artículo científico publicado en 2016

Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial

artículo científico publicado en 2016

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study

scientific article published on 24 April 2019

Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study

scientific article published on 19 December 2019

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis

artículo científico publicado en 2016

Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial

artículo científico publicado en 2015

Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update

artículo científico publicado en 2011

Treatment of osteoarthritis with continuous versus intermittent celecoxib

artículo científico publicado en 2011

Trial Characteristics as Contextual Factors when Evaluating Targeted Therapies in Patients with Psoriatic Disease: A Meta-Epidemiological Study

artículo científico publicado en 2017

Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort

artículo científico publicado en 2008

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: A sub-analysis of the Phase 3 SELECT-EARLY study

artículo científico publicado en 2020

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

artículo científico publicado en 2014

Updating the OMERACT filter: discrimination and feasibility

artículo científico

Updating the OMERACT filter: implications for patient-reported outcomes

artículo científico

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity

artículo científico publicado en 2014

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

artículo científico publicado en 2017

Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials

artículo científico publicado en 2011

Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers

artículo científico publicado en 2004

Worker productivity outcome measures in arthritis.

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda